CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 626 enrolled
Drug / intervention
Triclosan, Silicon dioxide, fluoride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00763269
NCT00763269Phase 3Completed
CompareCT.gov

The Efficacy of a Toothpaste to Reduce Sensitivity

Colgate Palmolive·interventional·Posted Sep 30, 2008·Updated Mar 7, 2012

In Brief

A Phase 3 clinical trial evaluating Triclosan, Silicon dioxide, fluoride and Triclosan, fluoride for Dentin Hypersensitivity. Completed, enrolled 626 participants across 1 site.

Detailed Summary

Hypersensitivity

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentin Hypersensitivity
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 30, 2008
Enrollment StartSep 1, 2008
Primary CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 17.8 years ago

Interventions

Triclosan, Silicon dioxide, fluoridedrug

Brush twice daily

Triclosan, fluoridedrug

Brush twice daily